#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin cancer Congenital nephrogenic diabetes insipidus Autoimmune hepatitis IPEX syndrome Diffuse large B-cell lymphoma recurrent Hyperinsulinaemic hypoglycaemia Interstitial lung disease Haemophilia A without inhibitors Metastatic malignant melanoma Neuroendocrine cell hyperplasia of infancy Angiosarcoma recurrent Immunodeficiency Neurotrophic keratopathy Malignant fibrous histiocytoma Uterine leiomyosarcoma More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Diagnostics Sarcoma – Treatment Stevens-Johnson syndrome – Trials in Disease Pemphigus – Trials in Disease Splenic marginal zone lymphoma – Diagnostics Acute respiratory distress syndrome – Trials in Disease Urea cycle disorder Acquired haemophilia – Life with Disease Activated PI3 kinase delta syndrome – Diagnostics Retinitis pigmentosa – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anifrolumab Tralokinumab Selgantolimod Clotrimazole Human Fibrinogen Dsimc CHLORMADINONE ACETATE Cetrorelix Pemetrexed Sodium Lactate Solution Tovinontrine Propylene Glycol Taminadenant Glycerol Phenylbutyrate Promethazine Hydrochloride Ibuprofen Ide397 Fluasterone Kd050 Alizapride More therapies…

    Learn about Your Condition

    Pancreatic failure Toxic nodular goitre Neuropathy peripheral Pneumonia chlamydial Drug use disorder Post procedural hypotension Alveolar proteinosis Turner's syndrome Bone sarcoma Choroidal dystrophy Osteopenia Tooth loss Hand fracture Generalised anxiety disorder Hodgkin's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Goserelin Acetate
    France

  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Albumin Solution
    • Indocyanine Green
    France

  • Study on Zoledronic Acid for Treating Osteosarcoma in Children, Adolescents, and Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    France

  • Study on Adjuvant Treatment for Unilateral Retinoblastoma with Vincristine Sulfate and Drug Combination in Patients After Primary Eye Removal

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Carboplatin
    • Cyclophosphamide
    • Etoposide
    France

  • Study of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor

    Not recruiting

    3 1
    Investigated Diseases:
    • Giant cell tumour of tendon sheath
    Investigated Drugs:
    • Emactuzumab
    Austria Belgium France Italy The Netherlands Poland +2

  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer female
    • Breast cancer male
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Cisplatin
    Austria Belgium France Germany Ireland Spain

  • Study on SENS-401 to Prevent Hearing Loss Caused by Cisplatin in Adults with Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • R-Azasetron Besilate
    France

  • Study of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Ductal adenocarcinoma of pancreas
    • Non-small cell lung cancer
    Investigated Drugs:
    • Amg 193
    Austria Belgium France Germany

  • Study on the Effectiveness of Lenvatinib for Patients with Advanced Gastrointestinal Stromal Tumors After Imatinib and Sunitinib Treatment Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Lenvatinib
    France

  • Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Docetaxel
    • Methotrexate
    Belgium Czechia France Germany Greece Hungary +6
Previous Page
1 … 16 17 18 19 20 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!